Inactive Instrument

Press Releases Elite Pharmaceuticals, Inc. Other OTC

Equities

ELTP

US28659T2006

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 Ended December 31, 2023 and Provides Conference Call Information	Feb. 15	AQ
Elite Pharmaceuticals, Inc. To Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024	Feb. 09	AQ
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant	Dec. 27	AQ
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 Ended September 30, 2023 and Provides Conference Call Information	Nov. 15	AQ
"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOM	23-10-31	AQ
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	23-09-25	AQ
Medical Penny Stocks Making Moves (ORHB, PBIO, INND, ELTP)	23-09-21	AQ
Penny Stocks In The News Making Moves: EPAZ, HYSR, ELTP, ABML	23-08-30	AQ
This Week's Top OTC Nano-Caps (ATVK, ELTP, EBET, ENZC)	23-08-28	AQ
Discover the Potential: "Top Penny Stocks to Watch Now": SNNC, TIVC, ENZC, ELTP, CLNV	23-08-23	AQ
CapitalGainsReport: Top Stocks Under Two Cents To Radar Today (ATVK, VDRM, RNVA, ELTP)	23-08-22	AQ
CapitalGainsReport: Exploring OTC Penny Stocks' Critical Updates (EPAZ, OZSC, ELTP, SHMP)	23-08-16	AQ
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 Ended June 30, 2023 and Provides Conference Call Information	23-08-15	AQ
Elite Pharmaceuticals, Inc. To Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023	23-08-10	AQ
CapitalGainsReport: Unearthing Penny Stock Potential CAVR, SHMP, ELTP, VPLM	23-07-28	AQ
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information	23-06-30	AQ
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer	23-05-04	AQ
ELITE PHARMACEUTICALS INC /NV/ : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-05-03	AQ
ELITE PHARMACEUTICALS INC /NV/ : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-20	AQ
ELITE PHARMACEUTICALS INC /NV/ : Change in Directors or Principal Officers (form 8-K)	23-02-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Elite Pharmaceuticals, Inc. Other OTC

Equities

ELTP

US28659T2006

Press Releases

Filters